Obtaining reference intervals traceable to reference measurement systems: Is it possible, who is responsible, what is the strategy?

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 5, 2012, Pages 813-817

  Panteghini, Mauro ^a   Ceriotti, Ferruccio ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Reference values; Standardization; Traceability

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ASSAY; BODY WEIGHT; HUMAN; LABORATORY; PRIORITY JOURNAL; QUALITY CONTROL; REFERENCE VALUE; REVIEW; STANDARDIZATION;

CLINICAL LABORATORY TECHNIQUES; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84867797654     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.828     Document Type: Review

References (28)

1. McLawhon RW. Patient safety and clinical effectiveness as imperatives for achieving harmonization inside and outside the clinical laboratory. Clin Chem 2011;57:936-8.
2. Panteghini M. Traceability, reference systems and result comparability. Clin Biochem Rev 2007;28:97-104.
3. Panteghini M. Traceability as a unique tool to improve standardization in laboratory medicine. Clin Biochem 2009;42:236-40.
4. Panteghini M. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement. Clin Chem Lab Med 2010;48:7-10.
5. ISO 17511:2003. In vitro diagnostic medical devices-measurement of quantities in biological samples-Metrological trace-ability of values assigned to calibrators and control materials. Geneva, Switzerland: ISO, 2003.
6. Büttner J. Laboratory findings: structure, validity and signifi-cance for medical cognitive processes. Eur J Clin Chem Clin Biochem 1991;29:507-19.
7. Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009;46:8-17.
8. Infusino I, Schumann G, Ceriotti F, Panteghini M. Standardization in clinical enzymology: a challenge for the theory of metrologi-cal traceability. Clin Chem Lab Med 2010;48:301-7.
9. Panteghini M. Implementation of standardization in clinical practice: not always an easy task. Clin Chem Lab Med 2012; DOI 10.1515/CCLM.2011.791.
10. Ceriotti F. Reference intervals in the new millenium. Biochim Clin 2007;31:254-66.
11. Dutta A, Saha C, Johnson CS, Chalasani N. Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study. Hepatology 2009;50:1957-62.
12. Friedberg RC, Souers R, Wagar EA, Stankovic AK, Valenstein PN. The origin of reference intervals. A College of American Pathologists Q-Probes study of "normal ranges" used in 163 clinical laboratories. Arch Pathol Lab Med 2007;131:348-57.
13. AGA Institute Medical Position Statement on Acute Pancreatitis. Gastroenterology 2007;132:2019-21.
14. Langdon DE, Leeper CK. Physician liberation units system. N Engl J Med 1970;283:1413.
15. Haeckel R, Wosniok W. Quantity quotient reporting. A proposal for a standardized presentation of laboratory results. Clin Chem Lab Med 2009;47:1203-6.
16. Férard G, Imbert-Bismut F, Messous D, Piton A, Ueda S, Poynard T, et al. A reference material for traceability of aspartate aminotransferase (AST) results. Clin Chem Lab Med 2005;43:549-53.
17. Ceriotti F. Prerequisites for use of common reference intervals. Clin Biochem Rev 2007;28:115-21.
18. Ceriotti F, Boyd JC, Klein G, Henny J, Queraltó J, Kairisto V, et al. On behalf of the IFCC Committee on Reference Intervals Decision Limits (C-RIDL). Reference intervals for serum crea-tinine concentrations: assessment of available data for global application. Clin Chem 2008;54:559-66.
19. Panteghini M. Enzymatic assays for creatinine: time for action. Clin Chem Lab Med 2008;46:567-72.
20. Ceriotti F, Henny J, Queraltó J, Ziyu S, Özarda Y, Chen B, et al. Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl trans-ferase (GGT) in serum: results from an IFCC multicenter study. Clin Chem Lab Med 2010;48:1593-601.
21. Schumann G, Klauke R, Canalias F, Bossert-Reuther S, Franck PF, Gella FJ, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 ° C. Part 9: reference procedure for the measurement of catalytic concentration of alkaline phosphatase. Clin Chem Lab Med 2011;49:1439-46.
22. Boyd JC. Cautions in the adoption of common reference intervals. Clin Chem 2008;54:238-9.
23. Petit Clerc C, Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1987;25:639-44.
24. Panteghini M. A critical appraisal of experimental factors influ-encing the definition of the 99th percentile limit for cardiac tro-ponins. Clin Chem Lab Med 2009;47:1179-82.
25. Alatalo P, Koivisto H, Kultti J, Bloigu R, Niemela O. Evaluation of reference intervals for biomarkers sensitive to alcohol consumption, excess body weight and oxidative stress. Scand J Clin Lab Invest 2010;70:104-11.
26. Ichihara K. Study design: strategy for collaboration in the definition of reference intervals. Clin Chem Lab Med 2011;49:S69.
27. Ioannou GN. Implications of elevated serum alanine amin-otransferase levels: think outside the liver. Gastroenterology 2008;135:1851-4.
28. CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved guideline, 3rd ed. CLSI document C28-A3c. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.